Company
United StatesDanny H. Sugimoto, M.D., Chicago, IL – FDA Inspections
Inspection records and compliance data for Danny H. Sugimoto, M.D. in Chicago, Illinois. 5 FDA inspections on record, last inspected May 23, 2019.
Company Profile
This profile covers Danny H. Sugimoto, M.D. based in Chicago, Illinois, United States.
FDA Inspection History
- FDA inspections
- 5
- OAI
- 0
- VAI
- 4
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected February 23, 2009. Last inspected May 23, 2019.
Most cited issue areas
- FD-1572, protocol compliance3 inspections
- Accountability records1 inspection
- Case history records- inadequate or inadequate1 inspection
FDA inspections (5)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| May 23, 2019 | NAI | Human Drugs · Bioresearch Monitoring | 1092841 |
| May 20, 2015 | VAI | Human Drugs · Bioresearch Monitoring | 926019 |
| May 20, 2015 | VAI | Human Drugs · Bioresearch Monitoring | 923844 |
| January 2, 2014 | VAI | Human Drugs · Bioresearch Monitoring | 860826 |
| February 23, 2009 | VAI | Human Drugs · Bioresearch Monitoring | 571974 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Danny H. Sugimoto, M.D.
FEI Number
3007207764
Address
Cedar-Crosse Research Center, 800 S Wells St Ste M15, Chicago, Illinois 60607, United States
Country
United States
ID: dc781d15-5f74-42bd-b6cc-13f572ac50b9